PHARMACORP RX INC (PCRX.CA) Stock Cash Flow
TSX-V:PCRX - TSX Venture Exchange - CA71714X1050 - Common Stock - Currency: CAD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | N/A | -1.05M | -470.40K | -517.10K | -25.80K | |||
| Depreciation Amortization | N/A | 289.90K | N/A | N/A | N/A | |||
| Income Taxes - Deferred | N/A | -137.60K | N/A | N/A | N/A | |||
| Change In Working Capital | N/A | 708.10K | -49.00K | 10.60K | 26.30K | |||
| Other non cash items | N/A | 315.60K | 0.00 | 386.30K | 0.00 | |||
| OPERATING CASH FLOW | N/A | 125.00K | -519.50K | -120.20K | 500.00 | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -6.90K | N/A | N/A | N/A | |||
| Other Investing Activity | N/A | -16.86M | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | N/A | -16.86M | N/A | N/A | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -107.10K | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | N/A | 27.49M | 27.80K | 2.00M | 1.00M | |||
| Other Financing Activity | N/A | N/A | 0.00 | -126.50K | -20.50K | |||
| FINANCING CASH FLOW | N/A | 27.38M | 27.80K | 1.87M | 979.50K | |||
| CHANGE IN CASH | N/A | 10.64M | -491.60K | 1.75M | 980.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | N/A | 125.00K | -519.50K | -120.20K | 500.00 | |||
| Capital Expenditure | N/A | -6.90K | N/A | N/A | N/A | |||
| FREE CASH FLOW | N/A | 118.10K | -519.50K | -120.20K | 500.00 | |||
All data in CAD